Bromide

Bromide

SCHEMBL2347284

Br.CC1=C(C)N(OCc2ccccc2)CN1Cc1ccccc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
TSHR P16473 1/20 0.38
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAPK14 Q16539 1/20 0.38
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
CYP2C19 P33261 1/20 0.36
GRM2 Q14416 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL2353150 0.81 SIGMAR1 (0.39) ALDH1A1MEN1HPGDHTTKMT2A
SCHEMBL4084447 0.79 LMNA (0.48) ALDH1A1MEN1HTTKMT2ALMNA
Hydrochloric Acid SCHEMBL4081730 0.77 LMNA (0.47) ALDH1A1MEN1HTTKMT2ALMNA
Bromide SCHEMBL27643550 0.75 ALDH1A1 (0.41) ALDH1A1MEN1HPGDHTTKMT2A
SCHEMBL27624228 0.73 ALDH1A1 (0.41) ALDH1A1MEN1HPGDHTTKMT2A
SCHEMBL28598923 0.66 TSHR (0.50) ALDH1A1TSHRLMNACYP2C19
SCHEMBL28946773 0.66 POLB (0.50) ALDH1A1MEN1KMT2ALMNAPOLB
SCHEMBL13386604 0.65 ALDH1A1 (0.55) ALDH1A1TSHR
SCHEMBL28062275 0.65 MC4R (0.43) ALDH1A1MEN1HTTKMT2ALMNA
Bromide SCHEMBL1046939 0.64 BRD4 (0.50) MEN1HTTKMT2ALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1576039-B1 CATALYTIC DEPOLYMERIZATION OF POLYMERS CONTAINING ELECTROPHILIC LINKAGES USING NUCLEOPHILIC REAGENTS IBM (US) 2011-08-03 EP disclosed
US-7544800-B2 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2009-06-09 US disclosed
US-7053221-B2 Heteroatom-stabilized carbenes and precursors thereto as depolymerization catalysts INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2006-05-30 US disclosed
US-20050288508-A1 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2005-12-29 US disclosed
US-6916936-B2 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2005-07-12 US disclosed
US-6911546-B2 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2005-06-28 US disclosed
US-20050049418-A1 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents HEDRICK JAMES LUPTON (US) 2005-03-03 US disclosed
US-20040127720-A1 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents NATIONAL SCIENCE FOUNDATION 2004-07-01 US disclosed
US-20040127744-A1 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents NATIONAL SCIENCE FOUNDATION 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288508-A1 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents POLL, PNKP, PARN ALDH1A1 3878/4885TSHR 4334/4885MEN1 3011/4885
US-20050049418-A1 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents POLL, PNKP, PARN ALDH1A1 3878/4885TSHR 4334/4885MEN1 3011/4885
US-20040127744-A1 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents POLL, PNKP, PARP1 ALDH1A1 3798/4885TSHR 4327/4885MEN1 3037/4885
US-20040127720-A1 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents POLL, PNKP, PARP1 ALDH1A1 3798/4885TSHR 4327/4885MEN1 3037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.